Pan-cancer analysis of antibody-drug conjugate targets and putative predictors of treatment response

Antibody-drug conjugates (ADCs) are a rapidly expanding class of compounds in oncology. Our goal was to assess the expression of ADC targets and potential down-stream determining factors of activity across pan-cancer and normal tissues.

Source: European Journal of Cancer - October 11, 2023 Category: Cancer & Oncology Authors: Carlo Bosi, Áron Bartha, Barbara Galbardi, Giulia Notini, Matteo M. Naldini, Luca Licata, Giulia Viale, Marco Mariani, Barbara Pistilli, H Raza Ali, Fabrice Andre, Marta Piras, Maurizio Callari, Marco Barreca, Alberta Locatelli, Lucia Viganò, Carmen Cri Tags: Original Research Source Type: research